$0.1
+0.01
(+6.38%)▲
Live
8.9%
Downside
Day's Volatility :20.99%
Upside
13.27%
18.0%
Downside
52 Weeks Volatility :99.79%
Upside
99.74%
Period | Bluejay Diagnostics Inc | Index (Russel 2000) |
---|---|---|
3 Months | -85.06% | 0.0% |
6 Months | -98.1% | 0.0% |
1 Year | -99.73% | 0.0% |
3 Years | -99.99% | -23.0% |
Market Capitalization | 1.6M |
Book Value | $3.34 |
Earnings Per Share (EPS) | -43.04 |
Wall Street Target Price | 256.0 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -58.51% |
Return On Equity TTM | -125.25% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 48.9K |
EBITDA | -8.7M |
Diluted Eps TTM | -43.04 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 255900.0%
Sell
Neutral
Buy
Bluejay Diagnostics Inc is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Bluejay Diagnostics Inc | -34.22% | -98.1% | -99.73% | -99.99% | -99.99% |
Stryker Corporation | 0.83% | 12.78% | 40.21% | 33.69% | 71.83% |
Boston Scientific Corp. | 4.85% | 29.48% | 75.68% | 96.28% | 127.87% |
Edwards Lifesciences Corp. | 4.32% | -19.19% | 1.77% | -39.29% | -7.22% |
Abbott Laboratories | 3.99% | 11.51% | 24.65% | -4.53% | 46.22% |
Medtronic Plc | 2.65% | 14.48% | 27.42% | -24.18% | -13.49% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Bluejay Diagnostics Inc | NA | NA | NA | 0.0 | -1.25 | -0.59 | NA | 3.34 |
Stryker Corporation | 40.15 | 40.15 | 2.64 | 12.01 | 0.19 | 0.07 | 0.01 | 51.86 |
Boston Scientific Corp. | 70.26 | 70.26 | 2.14 | 2.41 | 0.09 | 0.05 | NA | 13.85 |
Edwards Lifesciences Corp. | 27.67 | 27.67 | 3.65 | 2.6 | 0.22 | 0.12 | NA | 12.35 |
Abbott Laboratories | 35.83 | 35.83 | 4.31 | 4.67 | 0.14 | 0.06 | 0.02 | 22.26 |
Medtronic Plc | 30.23 | 30.23 | 1.67 | 5.2 | 0.08 | 0.04 | 0.03 | 37.39 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Bluejay Diagnostics Inc | Sell | $1.6M | -99.99% | NA | 0.0% |
Stryker Corporation | Buy | $137.1B | 71.83% | 40.15 | 16.12% |
Boston Scientific Corp. | Buy | $127.3B | 127.87% | 70.26 | 12.0% |
Edwards Lifesciences Corp. | Buy | $42.3B | -7.22% | 27.67 | 23.74% |
Abbott Laboratories | Buy | $205.1B | 46.22% | 35.83 | 13.65% |
Medtronic Plc | Buy | $115.2B | -13.49% | 30.23 | 12.06% |
Insights on Bluejay Diagnostics Inc
In the last 1 year, Boston Scientific Corp. has given 76.0% return, outperforming this stock by 175.7%
Anson Funds Management LP
CVI Holdings LLC
Virtu Financial LLC
Warberg Asset Management LLC
Tower Research Capital LLC
bluejay diagnostics, inc. is a medical diagnostics company focused on improving patient outcomes using its symphony system, a cost-effective, rapid, near-patient product for triage and monitoring of disease progression.
Organization | Bluejay Diagnostics Inc |
Employees | 10 |
CEO | Mr. Indranil Dey |
Industry | Miscellaneous |
Jpmorgan Betabuilders 1-5 Year Us Aggregate Bd Etf
$0.10
+6.38%
Invesco Bulletshares 2025 Hi
$0.10
+6.38%
Schwab International Dividend Equity Etf
$0.10
+6.38%
Innovator Intl Developed 10 Buffer Etf - Quarterly
$0.10
+6.38%
Lightpath Technologies Inc
$0.10
+6.38%
Vaneck Vectors Global Alternative Energy Etf
$0.10
+6.38%
First Trust Flexible Municipal High Income Etf
$0.10
+6.38%
Drx Dly Reg Bank Bull 3x
$0.10
+6.38%
Graniteshares 2x Long Pltr Daily Etf
$0.10
+6.38%